Prevalence, genetic drift of haemagglutinin, and antiviral resistance of influenza A/H3N2 viruses circulating in Shanghai in children during 2009-2012-Reference-Cited by-同舟云学术

Prevalence, genetic drift of haemagglutinin, and antiviral resistance of influenza A/H3N2 viruses circulating in Shanghai in children during 2009-2012

Published:2014-02-13 Issue:6 Volume:86 Page:1026-1033
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Cai Jiehao¹,Wang Xiangshi¹,Zhao Baihui²,Yao Weilei¹,Wang Xiaohong¹,Zhu Qirong¹,Zeng Mei¹

Affiliation:

1. Department of Infectious Diseases; Children's Hospital of Fudan University; Shanghai China

2. Microbiology Department; Shanghai Municipal Center for Disease Control and Prevention; Shanghai China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference36 articles.

1. Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011;Ann;J Clin Virol,2012

2. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season;Barr;Vaccine,2010

3. Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child;Baz;Clin Infect Dis,2006

4. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: A cause for concern;Bright;Lancet,2005

5. Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer;Carr;Pediatr Infect Dis J,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 therapeutics for low- and middle-income countries: a review of re-purposed candidate agents with potential for near-term use and impact;2021-03-24

2. The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus;Vaccine;2020-08

3. Charged amino acid variability related to N-glyco -sylation and epitopes in A/H3N2 influenza: Hem -agglutinin and neuraminidase;PLOS ONE;2017-07-14

4. Activity of Ergoferon against lethal influenza A (H3N2) virus infection in mice;Antiviral therapy;2016

5. Predicting clinical severity based on substitutions near epitope A of influenza A/H3N2;Infection, Genetics and Evolution;2015-08